BCX Bioceltix S.A.

15.78USD63.40 PLN · GPW-4.08%Mkt Cap: 87.29M USDP/E: —

Bioceltix S.A. engages in the development of veterinary biologics based on mesenchymal stem cells. The company's products include BCX-CM-J, a stem-cell based medicinal drug for the treatment of osteoarthritis in dogs; BC…